Rank | Gene Set | Z-score |
---|---|---|
1 | microglial cell activation (GO:0001774) | 6.88841505 |
2 | modulation by symbiont of host defense response (GO:0052031) | 6.42710951 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.42710951 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.42710951 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.42710951 |
6 | modulation by symbiont of host immune response (GO:0052553) | 6.42710951 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.42710951 |
8 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.97378380 |
9 | glycosphingolipid catabolic process (GO:0046479) | 5.69759859 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.62399749 |
11 | glycolipid catabolic process (GO:0019377) | 5.14745766 |
12 | cellular response to exogenous dsRNA (GO:0071360) | 5.13215650 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.88654759 |
14 | ceramide catabolic process (GO:0046514) | 4.77491199 |
15 | oligosaccharide catabolic process (GO:0009313) | 4.36614228 |
16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.22098330 |
17 | response to host immune response (GO:0052572) | 4.22098330 |
18 | macrophage activation involved in immune response (GO:0002281) | 4.17039136 |
19 | positive regulation of antigen processing and presentation (GO:0002579) | 4.09445993 |
20 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.97101555 |
21 | macrophage activation (GO:0042116) | 3.93158712 |
22 | positive regulation of interferon-alpha production (GO:0032727) | 3.92844795 |
23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.91742200 |
24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.91742200 |
25 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.87178771 |
26 | B cell mediated immunity (GO:0019724) | 3.86827632 |
27 | respiratory burst (GO:0045730) | 3.84502854 |
28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.78789798 |
29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.77555281 |
30 | response to host (GO:0075136) | 3.77502239 |
31 | response to host defenses (GO:0052200) | 3.77502239 |
32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.77502239 |
33 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.72156350 |
34 | regulation of interferon-alpha production (GO:0032647) | 3.70393549 |
35 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.62987986 |
36 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.60677740 |
37 | positive regulation of mast cell degranulation (GO:0043306) | 3.60677740 |
38 | cellular response to interferon-beta (GO:0035458) | 3.58873157 |
39 | Rac protein signal transduction (GO:0016601) | 3.56685694 |
40 | positive regulation of macrophage cytokine production (GO:0060907) | 3.56022330 |
41 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.49070781 |
42 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.48780107 |
43 | regulation of antigen processing and presentation (GO:0002577) | 3.44671772 |
44 | negative regulation of interleukin-12 production (GO:0032695) | 3.40524662 |
45 | amino sugar catabolic process (GO:0046348) | 3.33417067 |
46 | regulation of mast cell degranulation (GO:0043304) | 3.27762653 |
47 | regulation of lymphocyte migration (GO:2000401) | 3.25855064 |
48 | mast cell activation (GO:0045576) | 3.25814282 |
49 | phagocytosis, engulfment (GO:0006911) | 3.24927518 |
50 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.16862022 |
51 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.12659799 |
52 | import into cell (GO:0098657) | 3.11149384 |
53 | glycoside metabolic process (GO:0016137) | 3.09520491 |
54 | * intracellular pH reduction (GO:0051452) | 3.09170641 |
55 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.06834528 |
56 | I-kappaB phosphorylation (GO:0007252) | 3.06460018 |
57 | regulation of hypersensitivity (GO:0002883) | 3.06352014 |
58 | neutrophil activation (GO:0042119) | 3.05804098 |
59 | granulocyte activation (GO:0036230) | 3.05332960 |
60 | positive regulation of B cell differentiation (GO:0045579) | 3.04590359 |
61 | regulation of beta-amyloid formation (GO:1902003) | 3.03573623 |
62 | ganglioside metabolic process (GO:0001573) | 3.01774257 |
63 | L-amino acid import (GO:0043092) | 3.01369322 |
64 | regulation of chemokine biosynthetic process (GO:0045073) | 2.99532147 |
65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.97825189 |
66 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97531258 |
67 | purine nucleobase biosynthetic process (GO:0009113) | 2.96966154 |
68 | myeloid cell activation involved in immune response (GO:0002275) | 2.96478370 |
69 | response to thyroid hormone (GO:0097066) | 2.96169118 |
70 | regulation of monocyte chemotaxis (GO:0090025) | 2.95604145 |
71 | detection of other organism (GO:0098543) | 2.94790145 |
72 | regulation of superoxide anion generation (GO:0032928) | 2.93905104 |
73 | gonadal mesoderm development (GO:0007506) | 2.91656597 |
74 | neutrophil mediated immunity (GO:0002446) | 2.90456540 |
75 | * sphingolipid catabolic process (GO:0030149) | 2.89920547 |
76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89190132 |
77 | * pH reduction (GO:0045851) | 2.88958615 |
78 | positive regulation of T cell migration (GO:2000406) | 2.88525490 |
79 | response to peptidoglycan (GO:0032494) | 2.86122417 |
80 | positive regulation of leukocyte degranulation (GO:0043302) | 2.85998822 |
81 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.85772620 |
82 | phagosome maturation (GO:0090382) | 2.85412404 |
83 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85161974 |
84 | proteasome assembly (GO:0043248) | 2.84996413 |
85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83952568 |
86 | positive regulation of bone resorption (GO:0045780) | 2.82389635 |
87 | positive regulation of bone remodeling (GO:0046852) | 2.82389635 |
88 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81116355 |
89 | mannose metabolic process (GO:0006013) | 2.80661223 |
90 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.80127000 |
91 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.80065422 |
92 | regulation of B cell differentiation (GO:0045577) | 2.79497684 |
93 | negative regulation of mast cell activation (GO:0033004) | 2.78489962 |
94 | neutrophil activation involved in immune response (GO:0002283) | 2.76610654 |
95 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.76414816 |
96 | detection of bacterium (GO:0016045) | 2.75923285 |
97 | regulation of T cell migration (GO:2000404) | 2.75516900 |
98 | regulation of leukocyte degranulation (GO:0043300) | 2.73951429 |
99 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.73820261 |
100 | signal peptide processing (GO:0006465) | 2.73679053 |
101 | defense response to protozoan (GO:0042832) | 2.71225751 |
102 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.70595713 |
103 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.69723389 |
104 | purine nucleotide salvage (GO:0032261) | 2.69325569 |
105 | glucosamine-containing compound catabolic process (GO:1901072) | 2.68547835 |
106 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.67914232 |
107 | cellular extravasation (GO:0045123) | 2.67535664 |
108 | glycosylceramide metabolic process (GO:0006677) | 2.66407401 |
109 | negative regulation of osteoclast differentiation (GO:0045671) | 2.65364442 |
110 | detection of molecule of bacterial origin (GO:0032490) | 2.64357997 |
111 | histamine secretion (GO:0001821) | 2.63648148 |
112 | macrophage differentiation (GO:0030225) | 2.62748220 |
113 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.62501636 |
114 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.62501636 |
115 | detection of external biotic stimulus (GO:0098581) | 2.61716228 |
116 | negative regulation of ligase activity (GO:0051352) | 2.61021250 |
117 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.61021250 |
118 | positive regulation of interleukin-12 production (GO:0032735) | 2.59624965 |
119 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.59187227 |
120 | * membrane lipid catabolic process (GO:0046466) | 2.59071999 |
121 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.58613216 |
122 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.57956070 |
123 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.55658354 |
124 | IMP biosynthetic process (GO:0006188) | 2.55631483 |
125 | myeloid leukocyte activation (GO:0002274) | 2.55630561 |
126 | negative regulation of B cell proliferation (GO:0030889) | 2.55461028 |
127 | purine-containing compound salvage (GO:0043101) | 2.55131390 |
128 | response to interferon-beta (GO:0035456) | 2.54972182 |
129 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.54670420 |
130 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.53265642 |
131 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.53242830 |
132 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.51505157 |
133 | amyloid precursor protein catabolic process (GO:0042987) | 2.51292541 |
134 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.50573559 |
135 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.49527528 |
136 | regulation of mast cell activation (GO:0033003) | 2.49178978 |
137 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48906349 |
138 | immunoglobulin mediated immune response (GO:0016064) | 2.47763333 |
139 | NADPH regeneration (GO:0006740) | 2.47302596 |
140 | negative regulation of type 2 immune response (GO:0002829) | 2.46787383 |
141 | activated T cell proliferation (GO:0050798) | 2.45231081 |
142 | regulation of macrophage cytokine production (GO:0010935) | 2.44535087 |
143 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44281366 |
144 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.43233908 |
145 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.42746051 |
146 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.42719949 |
147 | positive regulation of lymphocyte migration (GO:2000403) | 2.42081025 |
148 | oxidative phosphorylation (GO:0006119) | 2.41727728 |
149 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.41686160 |
150 | positive regulation of mast cell activation (GO:0033005) | 2.41542506 |
151 | nucleobase biosynthetic process (GO:0046112) | 2.39188804 |
152 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.39002016 |
153 | response to protozoan (GO:0001562) | 2.38413270 |
154 | mast cell degranulation (GO:0043303) | 2.38073541 |
155 | mast cell activation involved in immune response (GO:0002279) | 2.38073541 |
156 | pentose-phosphate shunt (GO:0006098) | 2.37978447 |
157 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.36886221 |
158 | detection of biotic stimulus (GO:0009595) | 2.36601486 |
159 | leukocyte degranulation (GO:0043299) | 2.36257730 |
160 | myeloid dendritic cell activation (GO:0001773) | 2.35357156 |
161 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.35043246 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.39114206 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.42030244 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.33179346 |
4 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.64305856 |
5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.46847245 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.28049424 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.22576751 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.13584226 |
9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.04263057 |
10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.03604580 |
11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.90318255 |
12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.79556961 |
13 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.77880989 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64640705 |
15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53782031 |
16 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.48098955 |
17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46047241 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45479510 |
19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.44534957 |
20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40905334 |
21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29669221 |
22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.29651209 |
23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.26524394 |
24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25817097 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23270538 |
26 | * TFEB_21752829_ChIP-Seq_HELA_Human | 2.20620131 |
27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.14939599 |
28 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.08766223 |
29 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.07462414 |
30 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.05678639 |
31 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01089240 |
32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00471336 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99381035 |
34 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.99053678 |
35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96829371 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.96667047 |
37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.94976038 |
38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90947028 |
39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.88707909 |
40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84473111 |
41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83445412 |
42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.82635263 |
43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82516885 |
44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79904113 |
45 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.79709110 |
46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77195791 |
47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77088233 |
48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75811601 |
49 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.73349420 |
50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72863359 |
51 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.67148658 |
52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.64173388 |
53 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.63582868 |
54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63494903 |
55 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62965503 |
56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.60150950 |
57 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.59213049 |
58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.58919397 |
59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58341104 |
60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57434562 |
61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56910070 |
62 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52141995 |
63 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49299415 |
64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49231990 |
65 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48815762 |
66 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.48728374 |
67 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.47778215 |
68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44498908 |
69 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42509003 |
70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41522343 |
71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41354876 |
72 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.41242848 |
73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37471005 |
74 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35341127 |
75 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.33740295 |
76 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33668677 |
77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33142581 |
78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33114083 |
79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33059574 |
80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31647075 |
81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30404441 |
82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28966889 |
83 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.28653886 |
84 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.28646714 |
85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27515864 |
86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27121654 |
87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.26582208 |
88 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.24917752 |
89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.24487876 |
90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24450724 |
91 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24254425 |
92 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.22786249 |
93 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21787831 |
94 | * MYB_26560356_Chip-Seq_TH2_Human | 1.21712083 |
95 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.18393621 |
96 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18251510 |
97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17773777 |
98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17346078 |
99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17001816 |
100 | * MYB_26560356_Chip-Seq_TH1_Human | 1.16942724 |
101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15668461 |
102 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14782411 |
103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14686839 |
104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10944875 |
105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10351100 |
106 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.10234483 |
107 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10182146 |
108 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09815832 |
109 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09759146 |
110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09644641 |
111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09644641 |
112 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.09504481 |
113 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.09072347 |
114 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.07579132 |
115 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07551186 |
116 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07545295 |
117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06640259 |
118 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05914779 |
119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04150862 |
120 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03497432 |
121 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01785461 |
122 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01457475 |
123 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00765461 |
124 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.00445358 |
125 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99689129 |
126 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.99550467 |
127 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.99550467 |
128 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99454473 |
129 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98645927 |
130 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98392364 |
131 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98212893 |
132 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97572716 |
133 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96959092 |
134 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96661048 |
135 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96647152 |
136 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95218517 |
137 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94355192 |
138 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94078854 |
139 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93311910 |
140 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93210965 |
141 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93175713 |
142 | * MAF_26560356_Chip-Seq_TH1_Human | 0.92724275 |
143 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92208886 |
144 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92115808 |
145 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91679502 |
146 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91662027 |
147 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91458858 |
148 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91398591 |
149 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.91363802 |
150 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91323212 |
151 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90759546 |
152 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89283198 |
153 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.89197891 |
154 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88625624 |
155 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88388863 |
156 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88103779 |
157 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87893889 |
158 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87373838 |
159 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.87087076 |
160 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.86772414 |
161 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.85324487 |
162 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85256644 |
163 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85016263 |
164 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.82761568 |
165 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82463218 |
166 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.82356273 |
167 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.81927319 |
168 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.81833327 |
169 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.80647490 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 6.55998159 |
2 | MP0004147_increased_porphyrin_level | 3.48659640 |
3 | MP0003806_abnormal_nucleotide_metabolis | 3.47333311 |
4 | MP0005058_abnormal_lysosome_morphology | 3.18864911 |
5 | MP0005671_abnormal_response_to | 2.96336819 |
6 | MP0003172_abnormal_lysosome_physiology | 2.72181502 |
7 | MP0002148_abnormal_hypersensitivity_rea | 2.66924805 |
8 | MP0003183_abnormal_peptide_metabolism | 2.42498465 |
9 | MP0001790_abnormal_immune_system | 2.33222034 |
10 | MP0005387_immune_system_phenotype | 2.33222034 |
11 | MP0002419_abnormal_innate_immunity | 2.30299630 |
12 | MP0000685_abnormal_immune_system | 2.29711759 |
13 | MP0002452_abnormal_antigen_presenting | 2.14828119 |
14 | MP0009785_altered_susceptibility_to | 2.10385204 |
15 | MP0005000_abnormal_immune_tolerance | 2.10229499 |
16 | MP0003690_abnormal_glial_cell | 2.00300757 |
17 | MP0000920_abnormal_myelination | 1.99077999 |
18 | MP0005025_abnormal_response_to | 1.98503857 |
19 | MP0005310_abnormal_salivary_gland | 1.96633292 |
20 | MP0001819_abnormal_immune_cell | 1.95744932 |
21 | MP0003191_abnormal_cellular_cholesterol | 1.89444757 |
22 | MP0001958_emphysema | 1.84343639 |
23 | MP0008260_abnormal_autophagy | 1.83894271 |
24 | MP0002420_abnormal_adaptive_immunity | 1.83021835 |
25 | MP0001800_abnormal_humoral_immune | 1.77314057 |
26 | MP0002723_abnormal_immune_serum | 1.72618350 |
27 | MP0002166_altered_tumor_susceptibility | 1.69749136 |
28 | MP0003436_decreased_susceptibility_to | 1.67980987 |
29 | MP0005464_abnormal_platelet_physiology | 1.64232109 |
30 | MP0004510_myositis | 1.61110840 |
31 | MP0008007_abnormal_cellular_replicative | 1.59054539 |
32 | MP0001853_heart_inflammation | 1.58254415 |
33 | MP0002876_abnormal_thyroid_physiology | 1.57862419 |
34 | MP0001545_abnormal_hematopoietic_system | 1.54544530 |
35 | MP0005397_hematopoietic_system_phenotyp | 1.54544530 |
36 | MP0003724_increased_susceptibility_to | 1.54496105 |
37 | MP0010307_abnormal_tumor_latency | 1.54195661 |
38 | MP0003880_abnormal_central_pattern | 1.53355413 |
39 | MP0003300_gastrointestinal_ulcer | 1.52853221 |
40 | MP0010094_abnormal_chromosome_stability | 1.51855490 |
41 | MP0008058_abnormal_DNA_repair | 1.48796485 |
42 | MP0009840_abnormal_foam_cell | 1.45188066 |
43 | * MP0002064_seizures | 1.41990172 |
44 | MP0009278_abnormal_bone_marrow | 1.41111229 |
45 | MP0000343_altered_response_to | 1.40422566 |
46 | MP0000015_abnormal_ear_pigmentation | 1.40414627 |
47 | MP0003075_altered_response_to | 1.38791644 |
48 | MP0003866_abnormal_defecation | 1.38121707 |
49 | MP0003111_abnormal_nucleus_morphology | 1.35579004 |
50 | MP0003045_fibrosis | 1.35134936 |
51 | MP0006036_abnormal_mitochondrial_physio | 1.34069238 |
52 | MP0003656_abnormal_erythrocyte_physiolo | 1.32881049 |
53 | MP0005409_darkened_coat_color | 1.28074932 |
54 | MP0002396_abnormal_hematopoietic_system | 1.25772499 |
55 | MP0003786_premature_aging | 1.25410672 |
56 | MP0000681_abnormal_thyroid_gland | 1.25144128 |
57 | MP0003303_peritoneal_inflammation | 1.21317007 |
58 | MP0002272_abnormal_nervous_system | 1.20830561 |
59 | MP0003195_calcinosis | 1.20560909 |
60 | MP0003186_abnormal_redox_activity | 1.20440889 |
61 | MP0001533_abnormal_skeleton_physiology | 1.19673446 |
62 | MP0001905_abnormal_dopamine_level | 1.18434226 |
63 | MP0005451_abnormal_body_composition | 1.16951567 |
64 | MP0002722_abnormal_immune_system | 1.16085979 |
65 | MP0000716_abnormal_immune_system | 1.15965742 |
66 | MP0000569_abnormal_digit_pigmentation | 1.15606974 |
67 | MP0008438_abnormal_cutaneous_collagen | 1.15563453 |
68 | MP0005171_absent_coat_pigmentation | 1.14883532 |
69 | MP0003635_abnormal_synaptic_transmissio | 1.13386073 |
70 | MP0002254_reproductive_system_inflammat | 1.13022141 |
71 | MP0009745_abnormal_behavioral_response | 1.12561939 |
72 | MP0002405_respiratory_system_inflammati | 1.09240889 |
73 | MP0002933_joint_inflammation | 1.07609334 |
74 | MP0001845_abnormal_inflammatory_respons | 1.07475661 |
75 | MP0006035_abnormal_mitochondrial_morpho | 1.07380985 |
76 | MP0009384_cardiac_valve_regurgitation | 1.06709514 |
77 | MP0010386_abnormal_urinary_bladder | 1.05571335 |
78 | MP0003879_abnormal_hair_cell | 1.05224543 |
79 | * MP0009046_muscle_twitch | 1.05007418 |
80 | MP0005410_abnormal_fertilization | 1.03440344 |
81 | MP0003633_abnormal_nervous_system | 1.03397915 |
82 | MP0005503_abnormal_tendon_morphology | 1.03395419 |
83 | * MP0002572_abnormal_emotion/affect_behav | 1.02785848 |
84 | MP0008995_early_reproductive_senescence | 1.01985371 |
85 | MP0000371_diluted_coat_color | 1.01530986 |
86 | MP0002006_tumorigenesis | 1.01284664 |
87 | MP0004947_skin_inflammation | 1.00791621 |
88 | MP0000858_altered_metastatic_potential | 1.00457778 |
89 | MP0000358_abnormal_cell_content/ | 0.99458676 |
90 | MP0004742_abnormal_vestibular_system | 0.98946420 |
91 | MP0004859_abnormal_synaptic_plasticity | 0.98763071 |
92 | MP0005319_abnormal_enzyme/_coenzyme | 0.97592814 |
93 | MP0002736_abnormal_nociception_after | 0.97392238 |
94 | MP0003448_altered_tumor_morphology | 0.95460530 |
95 | MP0003329_amyloid_beta_deposits | 0.94348542 |
96 | MP0008057_abnormal_DNA_replication | 0.94217068 |
97 | MP0002398_abnormal_bone_marrow | 0.93043416 |
98 | MP0005408_hypopigmentation | 0.92647837 |
99 | MP0000604_amyloidosis | 0.91264758 |
100 | MP0001542_abnormal_bone_strength | 0.91217442 |
101 | MP0001727_abnormal_embryo_implantation | 0.90554927 |
102 | MP0004957_abnormal_blastocyst_morpholog | 0.90530551 |
103 | MP0001968_abnormal_touch/_nociception | 0.89409633 |
104 | * MP0002067_abnormal_sensory_capabilities | 0.88851565 |
105 | MP0005167_abnormal_blood-brain_barrier | 0.88200565 |
106 | MP0005165_increased_susceptibility_to | 0.87226602 |
107 | MP0009333_abnormal_splenocyte_physiolog | 0.86865689 |
108 | MP0005166_decreased_susceptibility_to | 0.86576296 |
109 | MP0006054_spinal_hemorrhage | 0.86445435 |
110 | MP0003693_abnormal_embryo_hatching | 0.86171614 |
111 | MP0003631_nervous_system_phenotype | 0.85935294 |
112 | MP0005647_abnormal_sex_gland | 0.85199440 |
113 | MP0003634_abnormal_glial_cell | 0.84529278 |
114 | MP0002998_abnormal_bone_remodeling | 0.83914054 |
115 | MP0000372_irregular_coat_pigmentation | 0.83515406 |
116 | MP0008569_lethality_at_weaning | 0.83127441 |
117 | MP0002877_abnormal_melanocyte_morpholog | 0.82607893 |
118 | MP0003878_abnormal_ear_physiology | 0.82415446 |
119 | MP0005377_hearing/vestibular/ear_phenot | 0.82415446 |
120 | MP0003632_abnormal_nervous_system | 0.82395604 |
121 | MP0009763_increased_sensitivity_to | 0.82300842 |
122 | MP0005595_abnormal_vascular_smooth | 0.82068740 |
123 | MP0001851_eye_inflammation | 0.81832344 |
124 | * MP0000689_abnormal_spleen_morphology | 0.81416096 |
125 | MP0009764_decreased_sensitivity_to | 0.80690096 |
126 | MP0002429_abnormal_blood_cell | 0.80553251 |
127 | MP0000465_gastrointestinal_hemorrhage | 0.80550536 |
128 | MP0001486_abnormal_startle_reflex | 0.79179405 |
129 | MP0000703_abnormal_thymus_morphology | 0.78904545 |
130 | MP0003077_abnormal_cell_cycle | 0.78179663 |
131 | MP0004381_abnormal_hair_follicle | 0.77477675 |
132 | MP0008004_abnormal_stomach_pH | 0.77369801 |
133 | MP0004142_abnormal_muscle_tone | 0.76904417 |
134 | MP0008469_abnormal_protein_level | 0.76716973 |
135 | MP0005646_abnormal_pituitary_gland | 0.74655366 |
136 | MP0002019_abnormal_tumor_incidence | 0.73407952 |
137 | MP0004808_abnormal_hematopoietic_stem | 0.72730060 |
138 | MP0002063_abnormal_learning/memory/cond | 0.72552087 |
139 | MP0002909_abnormal_adrenal_gland | 0.70427184 |
140 | MP0003828_pulmonary_edema | 0.70246631 |
141 | * MP0006082_CNS_inflammation | 0.70245280 |
142 | MP0002277_abnormal_respiratory_mucosa | 0.70070682 |
143 | * MP0002090_abnormal_vision | 0.68473733 |
144 | MP0002295_abnormal_pulmonary_circulatio | 0.68153189 |
145 | MP0005075_abnormal_melanosome_morpholog | 0.67799025 |
146 | MP0010155_abnormal_intestine_physiology | 0.67045590 |
147 | MP0005174_abnormal_tail_pigmentation | 0.66896783 |
148 | MP0001986_abnormal_taste_sensitivity | 0.66674767 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.53642860 |
2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.53642860 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.53642860 |
4 | Cerebral palsy (HP:0100021) | 4.43021016 |
5 | Recurrent abscess formation (HP:0002722) | 4.41024004 |
6 | Chronic obstructive pulmonary disease (HP:0006510) | 4.38581134 |
7 | Obstructive lung disease (HP:0006536) | 4.38581134 |
8 | Chronic otitis media (HP:0000389) | 4.32769612 |
9 | Vacuolated lymphocytes (HP:0001922) | 4.15624908 |
10 | Dysostosis multiplex (HP:0000943) | 3.86894912 |
11 | Recurrent bacterial skin infections (HP:0005406) | 3.61115893 |
12 | Agnosia (HP:0010524) | 3.53637039 |
13 | Stomatitis (HP:0010280) | 3.32482844 |
14 | Eczematoid dermatitis (HP:0000976) | 3.31410637 |
15 | Disinhibition (HP:0000734) | 3.25311436 |
16 | Meningitis (HP:0001287) | 3.23463485 |
17 | Acrocyanosis (HP:0001063) | 3.03614479 |
18 | Poor head control (HP:0002421) | 3.02176359 |
19 | Testicular atrophy (HP:0000029) | 2.98592556 |
20 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.97036265 |
21 | Mucopolysacchariduria (HP:0008155) | 2.97036265 |
22 | Emphysema (HP:0002097) | 2.96475939 |
23 | * Increased cerebral lipofuscin (HP:0011813) | 2.94194055 |
24 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.91892565 |
25 | J-shaped sella turcica (HP:0002680) | 2.86000659 |
26 | Nephritis (HP:0000123) | 2.82363588 |
27 | Abnormality of complement system (HP:0005339) | 2.77822099 |
28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76936677 |
29 | Chronic sinusitis (HP:0011109) | 2.75753693 |
30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.74931699 |
31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.74931699 |
32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.74931699 |
33 | Hemoptysis (HP:0002105) | 2.69976850 |
34 | Diminished motivation (HP:0000745) | 2.69403854 |
35 | * Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.68901273 |
36 | Mutism (HP:0002300) | 2.68704179 |
37 | IgM deficiency (HP:0002850) | 2.68239557 |
38 | Azoospermia (HP:0000027) | 2.64642904 |
39 | Abnormality of the pleura (HP:0002103) | 2.63352318 |
40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62728206 |
41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62728206 |
42 | Abnormality of macrophages (HP:0004311) | 2.60804126 |
43 | Myositis (HP:0100614) | 2.60332750 |
44 | Vasculitis (HP:0002633) | 2.59931807 |
45 | Gonadal dysgenesis (HP:0000133) | 2.58520492 |
46 | Apathy (HP:0000741) | 2.54519565 |
47 | Petechiae (HP:0000967) | 2.49843854 |
48 | Pulmonary fibrosis (HP:0002206) | 2.47366223 |
49 | Cellulitis (HP:0100658) | 2.43853427 |
50 | Recurrent skin infections (HP:0001581) | 2.43066296 |
51 | Skin rash (HP:0000988) | 2.42137039 |
52 | Recurrent viral infections (HP:0004429) | 2.40622660 |
53 | Agammaglobulinemia (HP:0004432) | 2.39780290 |
54 | Abnormality of binocular vision (HP:0011514) | 2.37713555 |
55 | Diplopia (HP:0000651) | 2.37713555 |
56 | Cardiomegaly (HP:0001640) | 2.35203446 |
57 | Colitis (HP:0002583) | 2.34811301 |
58 | Arthropathy (HP:0003040) | 2.34515493 |
59 | Amaurosis fugax (HP:0100576) | 2.33702319 |
60 | Basal ganglia calcification (HP:0002135) | 2.29692222 |
61 | Orchitis (HP:0100796) | 2.28692822 |
62 | Progressive neurologic deterioration (HP:0002344) | 2.27718236 |
63 | Clumsiness (HP:0002312) | 2.26249381 |
64 | Abnormality of the prostate (HP:0008775) | 2.25279764 |
65 | Gonadotropin excess (HP:0000837) | 2.24714657 |
66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24433432 |
67 | Restrictive lung disease (HP:0002091) | 2.23724643 |
68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23440984 |
69 | Degeneration of anterior horn cells (HP:0002398) | 2.22873701 |
70 | Abnormality of the anterior horn cell (HP:0006802) | 2.22873701 |
71 | Abnormality of the pericardium (HP:0001697) | 2.20941184 |
72 | Interstitial pulmonary disease (HP:0006530) | 2.20612448 |
73 | Type I transferrin isoform profile (HP:0003642) | 2.20206000 |
74 | Recurrent bronchitis (HP:0002837) | 2.17107943 |
75 | Mediastinal lymphadenopathy (HP:0100721) | 2.17080699 |
76 | Nasal polyposis (HP:0100582) | 2.15712511 |
77 | Pulmonary infiltrates (HP:0002113) | 2.15245687 |
78 | Mitral stenosis (HP:0001718) | 2.11123319 |
79 | Microvesicular hepatic steatosis (HP:0001414) | 2.10963955 |
80 | Multiple enchondromatosis (HP:0005701) | 2.10437010 |
81 | Axonal loss (HP:0003447) | 2.08937165 |
82 | Deformed sella turcica (HP:0002681) | 2.07846341 |
83 | * Loss of speech (HP:0002371) | 2.05863731 |
84 | Abnormality of the nasal mucosa (HP:0000433) | 2.04581004 |
85 | Abnormality of the basal ganglia (HP:0002134) | 2.03218707 |
86 | Hypokinesia (HP:0002375) | 2.02907688 |
87 | Urticaria (HP:0001025) | 2.02473705 |
88 | Focal motor seizures (HP:0011153) | 2.01870915 |
89 | Recurrent fungal infections (HP:0002841) | 1.99324222 |
90 | Purpura (HP:0000979) | 1.96578593 |
91 | Systemic lupus erythematosus (HP:0002725) | 1.96134902 |
92 | Inflammation of the large intestine (HP:0002037) | 1.96000311 |
93 | Gastrointestinal stroma tumor (HP:0100723) | 1.94943453 |
94 | Recurrent pneumonia (HP:0006532) | 1.93168717 |
95 | Osteomyelitis (HP:0002754) | 1.91284277 |
96 | Increased serum ferritin (HP:0003281) | 1.90120720 |
97 | Personality changes (HP:0000751) | 1.90046860 |
98 | Vertebral compression fractures (HP:0002953) | 1.89899918 |
99 | Encephalitis (HP:0002383) | 1.87089121 |
100 | B lymphocytopenia (HP:0010976) | 1.86606901 |
101 | Abnormality of B cell number (HP:0010975) | 1.86606901 |
102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86573590 |
103 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86573590 |
104 | Abnormal protein glycosylation (HP:0012346) | 1.86573590 |
105 | Abnormal glycosylation (HP:0012345) | 1.86573590 |
106 | Hepatosplenomegaly (HP:0001433) | 1.86492794 |
107 | Symptomatic seizures (HP:0011145) | 1.86490824 |
108 | Hypergammaglobulinemia (HP:0010702) | 1.86365897 |
109 | Upper motor neuron abnormality (HP:0002127) | 1.86307327 |
110 | Glomerulopathy (HP:0100820) | 1.86094527 |
111 | Abnormality of male internal genitalia (HP:0000022) | 1.85397630 |
112 | Supranuclear gaze palsy (HP:0000605) | 1.84739059 |
113 | Dementia (HP:0000726) | 1.84136929 |
114 | Neurofibrillary tangles (HP:0002185) | 1.83831585 |
115 | T lymphocytopenia (HP:0005403) | 1.82976182 |
116 | Combined immunodeficiency (HP:0005387) | 1.81772360 |
117 | Paralysis (HP:0003470) | 1.81448090 |
118 | Spastic paraparesis (HP:0002313) | 1.81043473 |
119 | Mucosal telangiectasiae (HP:0100579) | 1.80525393 |
120 | Polyneuropathy (HP:0001271) | 1.79346614 |
121 | Thrombocytosis (HP:0001894) | 1.79237097 |
122 | Acute necrotizing encephalopathy (HP:0006965) | 1.79095780 |
123 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.78252549 |
124 | Cortical visual impairment (HP:0100704) | 1.77897390 |
125 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.76746325 |
126 | Prolonged neonatal jaundice (HP:0006579) | 1.76731493 |
127 | Stridor (HP:0010307) | 1.76667373 |
128 | Recurrent sinusitis (HP:0011108) | 1.75466405 |
129 | Nausea (HP:0002018) | 1.74824516 |
130 | Gastrointestinal inflammation (HP:0004386) | 1.74369161 |
131 | Prostate neoplasm (HP:0100787) | 1.74302877 |
132 | Hypomagnesemia (HP:0002917) | 1.73922695 |
133 | IgG deficiency (HP:0004315) | 1.73824616 |
134 | Hepatocellular necrosis (HP:0001404) | 1.73533708 |
135 | Abnormality of lateral ventricle (HP:0030047) | 1.73027962 |
136 | Paresthesia (HP:0003401) | 1.73002505 |
137 | Panhypogammaglobulinemia (HP:0003139) | 1.72370319 |
138 | Abnormality of iron homeostasis (HP:0011031) | 1.71074821 |
139 | Abnormal spermatogenesis (HP:0008669) | 1.70853261 |
140 | Amyloidosis (HP:0011034) | 1.70699403 |
141 | Autoimmune thrombocytopenia (HP:0001973) | 1.70548209 |
142 | Acute encephalopathy (HP:0006846) | 1.70083177 |
143 | Hypoplasia of the odontoid process (HP:0003311) | 1.69984222 |
144 | Myocardial infarction (HP:0001658) | 1.69886363 |
145 | Increased CSF lactate (HP:0002490) | 1.68890971 |
146 | Abnormality of methionine metabolism (HP:0010901) | 1.68777199 |
147 | Retrobulbar optic neuritis (HP:0100654) | 1.68569775 |
148 | Optic neuritis (HP:0100653) | 1.68569775 |
149 | Anorexia (HP:0002039) | 1.68151717 |
150 | Gingivitis (HP:0000230) | 1.67906299 |
151 | Respiratory failure (HP:0002878) | 1.67425402 |
152 | Glomerulonephritis (HP:0000099) | 1.67091931 |
153 | Increased CSF protein (HP:0002922) | 1.67066138 |
154 | Albinism (HP:0001022) | 1.65795655 |
155 | Neuronal loss in central nervous system (HP:0002529) | 1.64631889 |
156 | Mitochondrial inheritance (HP:0001427) | 1.64475004 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K12 | 5.01098264 |
2 | MAP4K1 | 3.97744861 |
3 | EIF2AK3 | 3.12191234 |
4 | CDK19 | 3.02856377 |
5 | EIF2AK1 | 2.99402877 |
6 | CSF1R | 2.91447120 |
7 | NME2 | 2.87820527 |
8 | BLK | 2.75225799 |
9 | KIT | 2.71924666 |
10 | MYLK | 2.53061976 |
11 | BUB1 | 2.43165149 |
12 | EPHB1 | 2.36616942 |
13 | TNIK | 2.29345699 |
14 | OXSR1 | 2.19341878 |
15 | FES | 2.16148695 |
16 | TXK | 2.15217291 |
17 | SYK | 2.07540342 |
18 | IRAK4 | 1.99204915 |
19 | TBK1 | 1.87349343 |
20 | PBK | 1.77965407 |
21 | RIPK4 | 1.75541194 |
22 | STK16 | 1.75102205 |
23 | TRIM28 | 1.71834898 |
24 | MAP3K14 | 1.71331609 |
25 | CASK | 1.70276911 |
26 | GRK1 | 1.64501744 |
27 | TYK2 | 1.63791610 |
28 | TESK2 | 1.61078726 |
29 | BCKDK | 1.60827411 |
30 | ITK | 1.59922214 |
31 | TSSK6 | 1.59318250 |
32 | TEC | 1.58251336 |
33 | PDK2 | 1.44388113 |
34 | TAOK3 | 1.41257940 |
35 | VRK2 | 1.38529572 |
36 | CSK | 1.33020599 |
37 | NEK1 | 1.32335307 |
38 | LYN | 1.30054512 |
39 | MAP4K2 | 1.28601753 |
40 | BMPR1B | 1.25964883 |
41 | JAK1 | 1.24430088 |
42 | SRPK1 | 1.24422447 |
43 | TGFBR2 | 1.24241179 |
44 | NUAK1 | 1.24147669 |
45 | MST4 | 1.23493280 |
46 | TTK | 1.16367165 |
47 | FGR | 1.14638539 |
48 | MUSK | 1.13940311 |
49 | STK24 | 1.12214221 |
50 | BTK | 1.11267929 |
51 | STK39 | 1.10978839 |
52 | ZAP70 | 1.07001924 |
53 | MAP2K3 | 1.06938140 |
54 | HCK | 1.03278188 |
55 | ALK | 1.00386218 |
56 | MAP2K7 | 0.99583479 |
57 | ERN1 | 0.97968997 |
58 | ADRBK2 | 0.96858440 |
59 | PDK1 | 0.96756774 |
60 | STK10 | 0.95506899 |
61 | PLK2 | 0.94268121 |
62 | TNK2 | 0.93857360 |
63 | PLK3 | 0.93837039 |
64 | GRK7 | 0.93241999 |
65 | MAPKAPK5 | 0.93122949 |
66 | PRKCQ | 0.92445031 |
67 | CDK6 | 0.91738846 |
68 | IKBKE | 0.91095204 |
69 | SIK3 | 0.89515061 |
70 | BMPR2 | 0.87649150 |
71 | PIM2 | 0.85807254 |
72 | IKBKB | 0.84556654 |
73 | LCK | 0.83274910 |
74 | WNK1 | 0.82550735 |
75 | WNK3 | 0.82004346 |
76 | DAPK2 | 0.81988745 |
77 | MATK | 0.81556742 |
78 | MAP3K3 | 0.81435155 |
79 | DAPK1 | 0.80025994 |
80 | PTK2B | 0.78306442 |
81 | MKNK1 | 0.78203133 |
82 | EIF2AK2 | 0.75814560 |
83 | FER | 0.75114116 |
84 | CLK1 | 0.74278274 |
85 | MAPK13 | 0.72990163 |
86 | NEK9 | 0.72059607 |
87 | CSNK1G3 | 0.71398928 |
88 | PRKCH | 0.70270512 |
89 | FLT3 | 0.66872117 |
90 | MAP2K6 | 0.66776223 |
91 | CDC7 | 0.66526237 |
92 | MAPK15 | 0.65407161 |
93 | NTRK3 | 0.65098047 |
94 | PAK4 | 0.64926022 |
95 | WNK4 | 0.64186758 |
96 | GRK6 | 0.63510985 |
97 | TESK1 | 0.63271180 |
98 | MAP3K8 | 0.61668554 |
99 | CAMKK1 | 0.59628610 |
100 | CCNB1 | 0.58575138 |
101 | FYN | 0.56965481 |
102 | NEK6 | 0.55853649 |
103 | ABL2 | 0.55570981 |
104 | LRRK2 | 0.55032588 |
105 | CDK5 | 0.54294549 |
106 | ATR | 0.52866341 |
107 | PDPK1 | 0.51869379 |
108 | KDR | 0.51678856 |
109 | PRKCD | 0.51145069 |
110 | MAP3K5 | 0.50970883 |
111 | CSNK1G1 | 0.50412377 |
112 | MARK3 | 0.49745971 |
113 | YES1 | 0.49099988 |
114 | SGK494 | 0.49075255 |
115 | SGK223 | 0.49075255 |
116 | PKN1 | 0.48576128 |
117 | ZAK | 0.48534987 |
118 | PRKCE | 0.48401915 |
119 | MINK1 | 0.48082626 |
120 | NLK | 0.47832576 |
121 | ROCK2 | 0.47815071 |
122 | CSNK1G2 | 0.46988272 |
123 | MAPKAPK2 | 0.46406804 |
124 | RPS6KA4 | 0.46003726 |
125 | JAK3 | 0.45217223 |
126 | MAP3K1 | 0.42733837 |
127 | TRPM7 | 0.41973183 |
128 | SGK3 | 0.41659849 |
129 | PLK4 | 0.41622497 |
130 | IRAK2 | 0.41161652 |
131 | CSNK2A1 | 0.41013806 |
132 | PLK1 | 0.41010894 |
133 | MAPKAPK3 | 0.40264291 |
134 | PIK3CG | 0.40014080 |
135 | IRAK3 | 0.38978989 |
136 | UHMK1 | 0.38753050 |
137 | SGK2 | 0.38667768 |
138 | EGFR | 0.38611843 |
139 | CAMKK2 | 0.37674480 |
140 | TYRO3 | 0.37427560 |
141 | LIMK1 | 0.37314853 |
142 | ACVR1B | 0.37083961 |
143 | MAP3K13 | 0.37022763 |
144 | PRPF4B | 0.36330907 |
145 | SCYL2 | 0.36105853 |
146 | JAK2 | 0.35376836 |
147 | GRK5 | 0.35052398 |
148 | IGF1R | 0.34318373 |
149 | ERBB3 | 0.33963777 |
150 | NTRK2 | 0.33670577 |
151 | ABL1 | 0.31821006 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.21972256 |
2 | Proteasome_Homo sapiens_hsa03050 | 3.18509918 |
3 | * Lysosome_Homo sapiens_hsa04142 | 2.84285970 |
4 | Asthma_Homo sapiens_hsa05310 | 2.83251692 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.55573781 |
6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.44870448 |
7 | DNA replication_Homo sapiens_hsa03030 | 2.36599181 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18116828 |
9 | Protein export_Homo sapiens_hsa03060 | 2.09289546 |
10 | Mismatch repair_Homo sapiens_hsa03430 | 2.04041769 |
11 | Phagosome_Homo sapiens_hsa04145 | 1.97915724 |
12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.80291720 |
13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.77819535 |
14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76950987 |
15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68698531 |
16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62898765 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61636213 |
18 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.60159482 |
19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54982287 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54398681 |
21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52793223 |
22 | Malaria_Homo sapiens_hsa05144 | 1.52604555 |
23 | Salmonella infection_Homo sapiens_hsa05132 | 1.47535648 |
24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47259402 |
25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.46085679 |
26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43377135 |
27 | Base excision repair_Homo sapiens_hsa03410 | 1.42227254 |
28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41293246 |
29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37830501 |
30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37638683 |
31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36145976 |
32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34442969 |
33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33405242 |
34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.33258985 |
35 | Tuberculosis_Homo sapiens_hsa05152 | 1.30967413 |
36 | Morphine addiction_Homo sapiens_hsa05032 | 1.27870987 |
37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27813785 |
38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26998306 |
39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26926474 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.26240598 |
41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26016793 |
42 | Homologous recombination_Homo sapiens_hsa03440 | 1.23757509 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.23430117 |
44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21790131 |
45 | * Fatty acid elongation_Homo sapiens_hsa00062 | 1.20278667 |
46 | Nicotine addiction_Homo sapiens_hsa05033 | 1.18585370 |
47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18261683 |
48 | Salivary secretion_Homo sapiens_hsa04970 | 1.13625731 |
49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.12730227 |
50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11999150 |
51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11967995 |
52 | Renin secretion_Homo sapiens_hsa04924 | 1.11510819 |
53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11136472 |
54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10364657 |
55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10131336 |
56 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09258716 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.07393820 |
58 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06356942 |
59 | GABAergic synapse_Homo sapiens_hsa04727 | 1.05656083 |
60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04878230 |
61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04529308 |
62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04255247 |
63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04085209 |
64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03793224 |
65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98664691 |
66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97804542 |
67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96428630 |
68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95363106 |
69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93960600 |
70 | Platelet activation_Homo sapiens_hsa04611 | 0.93388166 |
71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93282154 |
72 | Spliceosome_Homo sapiens_hsa03040 | 0.91722858 |
73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88257542 |
74 | Influenza A_Homo sapiens_hsa05164 | 0.86488892 |
75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86028208 |
76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.84499533 |
77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82867931 |
78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81945616 |
79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81533560 |
80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81147495 |
81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80962525 |
82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80778158 |
83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80009345 |
84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79407442 |
85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78379831 |
86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77910808 |
87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77838064 |
88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77017305 |
89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76493557 |
90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75747459 |
91 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75466556 |
92 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75074564 |
93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74745141 |
94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74494634 |
95 | Measles_Homo sapiens_hsa05162 | 0.74273406 |
96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73521549 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.73189990 |
98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72978066 |
99 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.71901185 |
100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70817623 |
101 | Mineral absorption_Homo sapiens_hsa04978 | 0.70152721 |
102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69816746 |
103 | Legionellosis_Homo sapiens_hsa05134 | 0.69662450 |
104 | Allograft rejection_Homo sapiens_hsa05330 | 0.69193874 |
105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65618581 |
106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65036294 |
107 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64792760 |
108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63066313 |
109 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62818025 |
110 | Long-term depression_Homo sapiens_hsa04730 | 0.62336708 |
111 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61410930 |
112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60961338 |
113 | RNA transport_Homo sapiens_hsa03013 | 0.60447755 |
114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59378451 |
115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57559800 |
116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57411797 |
117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56479374 |
118 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56127136 |
119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56054126 |
120 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55723571 |
121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55567390 |
122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54607346 |
123 | RNA polymerase_Homo sapiens_hsa03020 | 0.54098297 |
124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53624171 |
125 | Amoebiasis_Homo sapiens_hsa05146 | 0.53315128 |
126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52958057 |
127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51640980 |
128 | RNA degradation_Homo sapiens_hsa03018 | 0.51310558 |
129 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51051932 |
130 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50501789 |
131 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50165961 |
132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50152080 |
133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49079885 |
134 | Axon guidance_Homo sapiens_hsa04360 | 0.48996983 |
135 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48745877 |
136 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48468501 |
137 | Taste transduction_Homo sapiens_hsa04742 | 0.48315599 |
138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48157952 |
139 | Peroxisome_Homo sapiens_hsa04146 | 0.47846283 |
140 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46978215 |
141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44899451 |
142 | Purine metabolism_Homo sapiens_hsa00230 | 0.44861036 |
143 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39350391 |
144 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37980284 |
145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37968440 |
146 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35452055 |
147 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33461497 |
148 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30111984 |
149 | Hepatitis B_Homo sapiens_hsa05161 | 0.28354694 |
150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27036655 |